| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/25/2005 | CN1620431A (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 05/25/2005 | CN1620424A Compounds for the treatment of inflammatory disorders |
| 05/25/2005 | CN1620414A 维生素d类似物 Vitamin d analogues |
| 05/25/2005 | CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 05/25/2005 | CN1620300A Method of administering bisphosphonates |
| 05/25/2005 | CN1620298A Tibolone in the treatment of complaints associated with the administration of drugs which prevent the synthesis of endogenous estrogen |
| 05/25/2005 | CN1620294A Pyrimidine A2b selective antagonist compounds, their synthesis and use |
| 05/25/2005 | CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors |
| 05/25/2005 | CN1620286A Compounds for blocking androgen receptors |
| 05/25/2005 | CN1620284A Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tool for producing it |
| 05/25/2005 | CN1618451A Traditional Chinese medicine composition for treating osteoporosis, and its prepn. method |
| 05/25/2005 | CN1618448A Medicine composition for treating osseous arthritis, and its prepn. method |
| 05/25/2005 | CN1618437A Traditional Chinese medicine for treating cervical vertebra disease |
| 05/25/2005 | CN1203071C Polysaccharidic esters of N-derivatives of glutamic acid |
| 05/25/2005 | CN1203070C Thrombin receptor antagonists |
| 05/25/2005 | CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient |
| 05/25/2005 | CN1202859C Chinese medicine for treating protrasion of lumber intervertebral disci |
| 05/25/2005 | CN1202853C Ointment for setting fractured bone due to trauma and preparation method thereof |
| 05/25/2005 | CN1202828C Use of diphosphonic acid in preparing medicine for treatment of vasculogenesis |
| 05/24/2005 | US6897319 Therapeutic drugs for treating central nervous system disorders |
| 05/24/2005 | US6897318 Process for making substituted pyrazoles |
| 05/24/2005 | US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole |
| 05/24/2005 | US6897226 NK-1 receptor active amine oxide prodrugs |
| 05/24/2005 | US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 05/24/2005 | US6897210 Anticancer agents; antiarthritic agents |
| 05/24/2005 | US6897207 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 05/24/2005 | US6897203 Polysaccharidic esters of retinoic acid |
| 05/24/2005 | US6896904 Multilayer crosslinking porous structure; prosthetic bones, drug delivery |
| 05/24/2005 | CA2211177C Agent for acting upon bone formation disturbances containing alkaline citrates, lactates and/or malates |
| 05/19/2005 | WO2005023288A8 Treatment of fibrotic disease |
| 05/19/2005 | WO2005014576A8 Isoquinolinone derivative, process for producing the same and use thereof |
| 05/19/2005 | WO2004075846A3 Pyrazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same |
| 05/19/2005 | US20050107616 Alpha-ketoamide derivatives as cathepsin k inhibitors |
| 05/19/2005 | US20050107462 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors |
| 05/19/2005 | US20050107457 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 05/19/2005 | US20050107428 Antiinflammatory agents; autoimmune diseases; rheumatic diseases; anticholesterol agents; cardiovascular disorders |
| 05/19/2005 | US20050107416 17-hydroxy 4-aza androstan -3-ones as androgen receptor modulators |
| 05/19/2005 | US20050107413 pyrimidine derivatives such as 4-Chloro-5,6-diphenyl-2-(trifluoromethyl)pyrimidine, used for the treatment of inflammation and immunological diseases |
| 05/19/2005 | US20050107406 Angiogenesis inhibitors |
| 05/19/2005 | US20050107388 Heteroaromatic urea derivatives as vr-1receptor modulators for treating pain |
| 05/19/2005 | US20050107384 to inhibit proliferative conditions, such as cancer and psoriasis; detecting or identifying a HDAC in a biological sample comprising detecting or measuring the formation of a complex between a labelled compound as defined in claim (I) and a HDAC |
| 05/19/2005 | US20050107375 Fused bicyclic pyridine derivatives as tachykinin receptor antagonists |
| 05/19/2005 | US20050107345 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/19/2005 | US20050107340 Protein kinase modulators; cancer, diabetes, hepatic cirrhosis, cardiovascular disease such as atherosclerosis, angiogenesis, immunological disease such as autoimmune disease (e.g., AIDS and lupus) and renal disease |
| 05/19/2005 | US20050107317 Nucleic acid molecule of the short-chain dehydrogenase gene family, an antibody, an aptamer or receptors, polypeptide encoded thereby; biodrug for treatment of metabolism of triglycerides, metabolic disorders as obesity, eating disorder, cachexia, diabetes mellitus, hypertension, heart disease |
| 05/19/2005 | US20050107292 Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components |
| 05/19/2005 | US20050106724 Self renewing dental follicle tissues for use in generating periodontal ligament like membrane structures; tissue repair and regenerative medicine |
| 05/19/2005 | US20050106683 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 05/19/2005 | US20050106679 Leptin proteins |
| 05/19/2005 | US20050106658 Remodeling and glycoconjugation of peptides |
| 05/19/2005 | US20050106581 Phosphodiesterase polypeptides for use in identifying modulators for prevention and treatment of inflammatory disease |
| 05/19/2005 | US20050106266 docosahexaenoic acid and a calcium compound (carbonate, hydroxide,sulfate) |
| 05/19/2005 | US20050106215 Food or pet food composition containing plant extract for bone health |
| 05/19/2005 | US20050106212 Using electrochemical mixture of metal compound and bioactive material; contacting substrate |
| 05/19/2005 | US20050106189 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 05/19/2005 | US20050106186 Percutaneous preparations |
| 05/19/2005 | US20050106154 GASP1: a follistatin domain containing protein |
| 05/19/2005 | US20050106144 Spondyloarthropathies |
| 05/19/2005 | US20050106142 Rheumatic arthritis; hepatitis c virus; autoimmune diseases ; nterfering with forming or binding of such; autoantigen |
| 05/19/2005 | US20050106140 Antagonistic anti-hfas ligand human antibodies and fragments thereof |
| 05/19/2005 | US20050106127 Graft to humans; culture product; removing cells; preservation |
| 05/19/2005 | CA2543199A1 Use of crth2 antagonist compounds in therapy |
| 05/18/2005 | EP1531153A1 Epothilone derivatives |
| 05/18/2005 | EP1530573A1 Condensed heterocyclic pyrazole derivatives as kinase inhibitors |
| 05/18/2005 | EP1530568A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE |
| 05/18/2005 | EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway |
| 05/18/2005 | EP1530565A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 05/18/2005 | EP1530483A2 T cell receptor cdr3 sequences and methods for detection |
| 05/18/2005 | EP1530477A1 COMBINATION THERAPY WITH p38 MAP KINASE INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS |
| 05/18/2005 | EP1530475A2 Pharmaceutical compositions comprising an allosteric carboxylic inhibitor of matrix metalloproteinase-13 and a selective inhibitor of cyclooxygenase-2 |
| 05/18/2005 | EP1530472A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors |
| 05/18/2005 | EP1530466A2 Use of lck inhibitor for treatment of immunologic diseases |
| 05/18/2005 | EP1404656B1 Benzimidazole derivatives for treating microglia-activation associated diseases such as inflammatory, allergic, infectious or autoimmune diseases |
| 05/18/2005 | EP1265860B1 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 05/18/2005 | EP1263724B1 Novel compounds |
| 05/18/2005 | EP1224204B1 Non-aromatic estrogenic steroids with a hydrocarbon substituent in position 11 |
| 05/18/2005 | EP0830138B1 Use of fibroblast growth factor analogues to stimulate bone growth |
| 05/18/2005 | CN1617884A Beta-amyloid binding factors and inhibitors thereof |
| 05/18/2005 | CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament |
| 05/18/2005 | CN1617855A Inhibitors of cytosolic phospholipase A2 |
| 05/18/2005 | CN1617715A Treating muscle wasting with selective androgen receptor modulators |
| 05/18/2005 | CN1617691A Prevention and treatment of androgen-deprivation induced osteoporosis |
| 05/18/2005 | CN1616474A Acetamido glucose devicative of indomethacin and its synthetic method and use |
| 05/18/2005 | CN1616452A 维生素d类似物 Vitamin d analogues |
| 05/18/2005 | CN1616076A Medicine for treating cardiocerebral vascular system disease and blood supply deficiency, medicine preparing method and preparation |
| 05/18/2005 | CN1616068A Chinese medicine decoction for treating neck-shoulder and waist-leg pain |
| 05/18/2005 | CN1616058A Chinese medicine compound rheumatism preparation for improving bioavailability and medicine effect and preparing method |
| 05/18/2005 | CN1615999A Medicine for treating bone and joint tuberculosis |
| 05/18/2005 | CN1615995A Cyclodextrin super molecular composition of Chinese medicine giant knutweed rhizome and its preparing method |
| 05/18/2005 | CN1615992A Medicinal wine for quick acting and radically rheumatic arthritis and its preparing method |
| 05/18/2005 | CN1615985A Plaster for treating neck, shoulder and waist and leg pain and its preparing method |
| 05/18/2005 | CN1615980A Active extract of lamtophlomis rotata and its preparing method and use |
| 05/18/2005 | CN1615972A Medicine for treating arthraligia caused by wind, cold and wetness evils and with beauty function and its preparing method |
| 05/18/2005 | CN1615968A Chinese medicine preparation bone setting powder for treating traumatic injury |
| 05/18/2005 | CN1615929A Medicine for treating wind-dampness syndrome |
| 05/18/2005 | CN1615890A Use of vitamin d compounds |
| 05/18/2005 | CN1615888A Medicine composition and its use |
| 05/18/2005 | CN1615875A Dispersive tablet having allopurinol and benzbromarone |
| 05/18/2005 | CN1615873A Azaindoles compound |
| 05/18/2005 | CN1615860A Use of raloxifene hydrochloride in preparing medicine for treating bone fracture slow union or nonunion symptom |